Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 6/20 | 0.60 |
| ▸ | NPC1 | O15118 | 3/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 10/20 | 0.57 |
| ▸ | HTT | P42858 | 8/20 | 0.57 |
| ▸ | LMNA | P02545 | 8/20 | 0.57 |
| ▸ | NR2F2 | P24468 | 4/20 | 0.53 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | GALR3 | O60755 | 2/20 | 0.51 |
| ▸ | NAMPT | P43490 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | PKM | P14618 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL120400 | 0.86 | PKM (0.61) | SMN1; SMN2LMNAALDH1A1PKMKMT2A | |
| SCHEMBL14034664 | 0.84 | RAB9A (0.58) | RAB9ANPC1SMN1; SMN2HTTLMNA | |
| SCHEMBL17372926 | 0.81 | RAB9A (0.77) | RAB9ANPC1SMN1; SMN2HTTLMNA | |
| SCHEMBL3923271 | 0.79 | SMN1; SMN2 (0.71) | RAB9ANPC1SMN1; SMN2HTTLMNA | |
| SCHEMBL17372930 | 0.77 | SMN1; SMN2 (0.68) | RAB9ANPC1SMN1; SMN2HTTLMNA | |
| SCHEMBL3006563 | 0.76 | ALDH1A1 (0.63) | SMN1; SMN2ALDH1A1KMT2A | |
| SCHEMBL14419632 | 0.75 | RAB9A (0.77) | RAB9ANPC1SMN1; SMN2HTTLMNA | |
| SCHEMBL3025163 | 0.74 | CNR2 (0.57) | NPC1SMN1; SMN2ALDH1A1MEN1PKM | |
| SCHEMBL31113705 | 0.74 | PKM (0.65) | SMN1; SMN2LMNAALDH1A1PKMKMT2A | |
| SCHEMBL27083360 | 0.74 | SMN1; SMN2 (0.73) | RAB9ANPC1SMN1; SMN2HTTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1860941-B1 | BIPHENYL-N-(4-PYRIDYL) METHYLSUFONAMIDES | BASF SE (DE) | 2008-11-12 | — | — | EP | disclosed |
| EP-1860941-B1 | BIPHENYL-N-(4-PYRIDYL) METHYLSUFONAMIDES | BASF SE (DE) | 2008-11-12 | — | — | EP | disclosed |
| US-20080161187-A1 | Controlling phytopathogenic harmful fungi and harmful arthropodes; combating arthropodal pestsprotecting crops, seeds and non-living materials from infestation by arthropodal pests; insecticides, pesticides, fungicides; miticides; agriculture; veterinary medicine | BASF AKTIENGESELLSCHAFT (DE) | 2008-07-03 | — | — | US | disclosed |
| US-20080161187-A1 | Controlling phytopathogenic harmful fungi and harmful arthropodes; combating arthropodal pestsprotecting crops, seeds and non-living materials from infestation by arthropodal pests; insecticides, pesticides, fungicides; miticides; agriculture; veterinary medicine | BASF AKTIENGESELLSCHAFT (DE) | 2008-07-03 | — | — | US | disclosed |
| US-20080161187-A1 | Controlling phytopathogenic harmful fungi and harmful arthropodes; combating arthropodal pestsprotecting crops, seeds and non-living materials from infestation by arthropodal pests; insecticides, pesticides, fungicides; miticides; agriculture; veterinary medicine | BASF AKTIENGESELLSCHAFT (DE) | 2008-07-03 | — | — | US | disclosed |
| CN-101141878-A | Biphenyl-n-(4-pyridyl)methylsulfonamides | BASF AG (DE) | 2008-03-12 | — | — | CN | disclosed |
| EP-1860941-A1 | BIPHENYL-N-(4-PYRIDYL) METHYLSUFONAMIDES | BASF AKTIENGESELLSCHAFT (DE) | 2007-12-05 | — | — | EP | disclosed |
| WO-2006097489-A1 | BIPHENYL-N-(4-PYRIDYL) METHYLSUFONAMIDES | BASF AKTIENGESELLSCHAFT (DE) | 2006-09-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080161187-A1 | Controlling phytopathogenic harmful fungi and harmful arthropodes; combating arthropodal pestsprotecting crops, seeds and non-living materials from infestation by arthropodal pests; insecticides, pesticides, fungicides; miticides; agriculture; veterinary medicine | PTPN21, PTPN1, PTPN14 | RAB9A 2586/4885NPC1 1358/4885SMN1; SMN2 2697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.